Tesamorelin is a laboratory-made version of a natural hormone signal that tells the pituitary gland to release growth hormone. Researchers study its effects on growth-hormone signalling and body-fat distribution. An authorised prescription version exists for one specific condition, which does not make this research listing a general weight-loss product.

Clinical research includes growth-hormone signalling and reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not established as a general wellness or weight-loss treatment.

It activates the GHRH receptor upstream of the pituitary, encouraging the body to release its own growth hormone.

An authorised prescription medicine exists for a specific HIV-lipodystrophy indication. Evidence and approval do not extend automatically to other purposes or research products.

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.